Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma

被引:2
|
作者
Chen, Jianan [1 ]
Zhang, Weibin [4 ]
Bao, Jingwen [5 ]
Wang, Kun [6 ]
Zhao, Qiannan [3 ]
Zhu, Yuli [3 ]
Chen, Yanling [2 ,3 ]
机构
[1] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Ultrasound, Shanghai, Peoples R China
[4] Fudan Univ, Huashan Hosp, Dept Ultrasound, Shanghai, Peoples R China
[5] Hexi Univ, Sch Med Sci, Zhangye, Peoples R China
[6] Binzhou Med Univ, Affiliated Hosp, Dept Ultrasound, Binzhou, Peoples R China
关键词
Ultrasound; Deep learning; Combined hepatocellular-cholangiocarcinoma; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; DIAGNOSIS; CLASSIFICATION; RESECTION;
D O I
10.1007/s00261-023-04089-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
ObjectivesThe current study developed an ultrasound-based deep learning model to make preoperative differentiation among hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular-cholangiocarcinoma (cHCC-ICC).MethodsThe B-mode ultrasound images of 465 patients with primary liver cancer were enrolled in model construction, comprising 264 HCCs, 105 ICCs, and 96 cHCC-ICCs, of which 50 cases were randomly selected to form an independent test cohort, and the rest of study population was assigned to a training and validation cohorts at the ratio of 4:1. Four deep learning models (Resnet18, MobileNet, DenseNet121, and Inception V3) were constructed, and the fivefold cross-validation was adopted to train and validate the performance of these models. The following indexes were calculated to determine the differential diagnosis performance of the models, including sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), F-1 score, and area under the receiver operating characteristic curve (AUC) based on images in the independent test cohort.ResultsBased on the fivefold cross-validation, the Resnet18 outperformed other models in terms of accuracy and robustness, with the overall training and validation accuracy as 99.73% (+/- 0.07%) and 99.35% (+/- 0.53%), respectively. Furthers validation based on the independent test cohort suggested that Resnet 18 yielded the best diagnostic performance in identifying HCC, ICC, and cHCC-ICC, with the sensitivity, specificity, accuracy, PPV, NPV, F1-score, and AUC of 84.59%, 92.65%, 86.00%, 85.82%, 92.99%, 92.37%, 85.07%, and 0.9237 (95% CI 0.8633, 0.9840).ConclusionUltrasound-based deep learning algorithm appeared a promising diagnostic method for identifying cHCC-ICC, HCC, and ICC, which might play a role in clinical decision making and evaluation of prognosis.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 50 条
  • [41] Nestin Expression in Combined Hepatocellular-cholangiocarcinoma and Hepatocellular Carcinoma and its Prognostic Significance
    Kwon, Minji
    Kim, Haeryoung
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1377 - S1378
  • [42] Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study
    Yang, Zhen
    Shi, Guangjun
    CANCER MEDICINE, 2022, 11 (03): : 692 - 704
  • [43] Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
    Joseph, Nancy M.
    Tsokos, Christos G.
    Umetsu, Sarah E.
    Shain, A. Hunter
    Kelley, Robin K.
    Onodera, Courtney
    Bowman, Sarah
    Talevich, Eric
    Ferrell, Linda D.
    Kakar, Sanjay
    Krings, Gregor
    JOURNAL OF PATHOLOGY, 2019, 248 (02): : 164 - 178
  • [44] Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma
    Sagrini, Elisabetta
    Iavarone, Massimo
    Stefanini, Federico
    Tovoli, Francesco
    Vavassori, Sara
    Maggioni, Marco
    Renzulli, Matteo
    Salvatore, Veronica
    Stefanescu, Horia
    Colombo, Massimo
    Bolondi, Luigi
    Piscaglia, Fabio
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (01) : 69 - 77
  • [45] The Outcome of Intrahepatic Cholangiocarcinoma and Combined Hepatocellular Carcinoma and Cholangiocarcinoma after Liver Transplantation Comparison with Hepatocellular Carcinoma.
    Park, Min-Su
    Lee, Kwang-Woong
    Choi, Young-Rok
    Kim, Hyeyoung
    Hong, Geun
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Shin, Woo Young
    LIVER TRANSPLANTATION, 2012, 18 : S162 - S162
  • [46] Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
    Xin Zhang
    Wen-Juan Huang
    Meng-Lin Zhang
    Wen Wang
    Ye Niu
    Rui-tao Wang
    Zeng-yao Liu
    BMC Gastroenterology, 22
  • [47] Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
    Zhang, Xin
    Huang, Wen-Juan
    Zhang, Meng-Lin
    Wang, Wen
    Niu, Ye
    Wang, Rui-Tao
    Liu, Zeng-Yao
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [48] Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma
    Yang, Zhuanbo
    Wang, Liming
    Zhai, Yirui
    Zhao, Jianjun
    Ye, Feng
    Wang, Shulian
    Jiang, Liming
    Song, Yan
    Sun, Yongkun
    Zhu, Ji
    Tang, Yuan
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Li, Ning
    Qi, Shunan
    Lu, Ningning
    Li, Ye-Xiong
    Zhao, Hong
    Chen, Bo
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 45
  • [49] RE-CLASSIFICATION OF COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA AND SMALL DUCT TYPE INTRAHEPATIC CHOLANGIOCARCINOMA BY GENETIC ALTERATIONS
    Sasaki, Motoko
    Sato, Yasunori
    Nakanuma, Yasuni
    HEPATOLOGY, 2024, 80
  • [50] A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma
    Tian, Meng-Xin
    He, Wen-Jun
    Liu, Wei-Ren
    Yin, Jia-Cheng
    Jin, Lei
    Tang, Zheng
    Jiang, Xi-Fei
    Wang, Han
    Zhou, Pei-Yun
    Tao, Chen-Yang
    Ding, Zhen-Bin
    Peng, Yuan-Fei
    Dai, Zhi
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    Shi, Ying-Hong
    JOURNAL OF CANCER, 2018, 9 (06): : 1025 - 1032